HSR23-120: Real-World Observations Show Beneficial Outcomes in Patients With NSCLC Treated With Pembrolizumab for More Than 2 Years
- Resource Type
- Source
- Journal of the National Comprehensive Cancer Network. 21:HSR23-120
- Subject
Oncology - Language
- ISSN
- 1540-1413
1540-1405